METHOD FOR TREATMENT OF PATIENTS WITH PULMONARY TUBERCULOSIS Russian patent published in 2017 - IPC A61K38/43 A61P31/06 

FIELD: medicine, pharmacy.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used in complex treatment of patients with pulmonary tuberculosis (PT). Pulmonary tuberculosis patients receive a course of treatment according to standard regimes. Starting from the first day of treatment, the patient receives Wobenzym orally during 60 days of daily dose of 1 tablet 2 times a day 30 minutes before eating. Additionally, the treatment includes oral administration of Tubosan, 1 capsule of 200 mg 1 time a day after meal, once in two days during 60 days. After 60 days from the start of treatment, Wobenzym and Tubosan are canceled, and the course of TB treatment is continued according to standard regimes.

EFFECT: increased efficiency of treatment by reducing infiltration resorption periods, decay cavity closure, abacillation and normalization of immune and cytokine status, reduction of frequency of common residual changes.

4 tbl, 2 ex